Malaria vaccine candidate safe and immunogenic following first-in-human trials

I think I have ADHD, how do I get a diagnosis? What might it mean for me?
14 September 2022
CBD shows health benefits in estrogen-deficient mice that model postmenopause
14 September 2022

Malaria vaccine candidate safe and immunogenic following first-in-human trials

Researchers from the Walter Reed Army Institute of Research (WRAIR) report the malaria vaccine FMP013 antigen and ALFQ adjuvant combination appears safe and immunogenic for adults in the first-in-human evaluation results published in the Vaccine journal.

Comments are closed.